Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.

Wagner, A.D.; Lordick, F.; Grabsch, H.I.; Terashima, M.; Terada, M.; Yoshikawa, T.; Boku, N.; Kataoka, K.; Smyth, E.C.; Mauer, M.; Haustermans, K.; Moehler, M.H.

doi:10.1016/j.ejca.2019.09.006

Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.

Details

Download: 1-s2.0-S0959804919307282-main.pdf (499.39 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0

Serval ID

serval:BIB_35163E169A37

Type

Article: article from journal or magazin.

Publication sub-type

Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.

Collection

Publications

Institution

UNIL/CHUV

Title

Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.

Journal

European journal of cancer

Author(s)

Wagner A.D., Lordick F., Grabsch H.I., Terashima M., Terada M., Yoshikawa T., Boku N., Kataoka K., Smyth E.C., Mauer M., Haustermans K., Moehler M.H.

ISSN

1879-0852 (Electronic)

ISSN-L

0959-8049

Publication state

Published

Issued date

01/2020

Peer-reviewed

Oui

Volume

124

Pages

67-76

Language

english

Notes

Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish

Abstract

The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in the multidisciplinary management of stage II-III gastric and gastro-oesophageal junction (GEJ) cancer. We seek to outline how these challenges are addressed in current trials of both groups. Key elements of future trials of EORTC and JCOG in this indication are described, and a joint vision on how multidisciplinary research of gastric and GEJ cancer patients should be organised is outlined.

Keywords

Esophageal Neoplasms/mortality, Esophageal Neoplasms/therapy, Esophagogastric Junction/pathology, Female, Humans, Male, Neoplasm Staging, Prognosis, Stomach Neoplasms/mortality, Stomach Neoplasms/therapy, Survival Analysis, Adjuvant, Chemotherapy, EORTC, Gastric, Immunotherapy, JCOG, Perioperative

URN

urn:nbn:ch:serval-BIB_35163E169A373

OAI-PMH

oai:serval.unil.ch:BIB_35163E169A37

DOI

10.1016/j.ejca.2019.09.006

Pubmed

31759294

Web of science

000503386800009

Open Access

Yes